Medication Safety Alert: Recalls for KidNaps Melatonin and Ibuprofen Tablets
Urgent Safety Update for Households Drug Recall
As a healthcare professional, my priority is ensuring that the medications in your cabinet are both effective and safe. Today, I am sharing a vital update regarding two separate medication recalls issued in February 2026. These recalls affect a common sleep aid for children and adults, as well as widely used over-the-counter pain relief. Drug Recall
While these recalls are often precautionary, they highlight the importance of “stability” and “packaging integrity”—two factors that determine if a medicine works as intended or if it has begun to degrade.
KidNaps (Melatonin) 1mg/1ml Oral Solution Recall
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 Medicines Recall for all batches of KidNaps (Melatonin) 1mg/1ml Oral Solution, manufactured by Sterling Pharmaceuticals Ltd and distributed by Veriton Pharma Ltd. Drug Recall
The Issue: Out of Specification (OOS) Results
During routine annual stability testing, investigators found that the product did not meet the required standards for appearance and total impurities. In simple terms, the medicine’s chemical makeup changed over time more than it should have. Drug Recall
What you should do:
The recall is currently being managed at the pharmacy and wholesaler level. However, if you have a bottle of KidNaps at home, you should:
- Check the label: Look for “Sterling Pharmaceuticals” or “Veriton Pharma.”
- Consult your pharmacist: While the MHRA notes that patients may continue their treatment out of “abundance of caution,” it is best to speak with your prescriber about a fresh supply from an unaffected batch.
- Affected Batches: All batches within expiry are included, specifically those with expiry dates ranging from March 2026 to September 2027.
Aspar Ibuprofen 200mg Tablets Packaging Alert
In a separate update, Aspar Pharmaceuticals has recalled specific batches of Ibuprofen 200mg Tablets and Ibucalm 200mg Tablets. This recall affects products sold under various brands, including Almus and Numark.
The Issue: Perforated Foil Packaging
The recall was triggered by the discovery of tiny holes (perforations) in the aluminium foil of the blister packs. When the foil is compromised, the tablets are exposed to air and moisture. This can lead to medication degradation, making the ibuprofen less effective or causing it to spoil before its expiration date.
How to spot the affected packs:
Check your medicine drawer for Ibuprofen or Ibucalm 200mg. The specifically affected batch numbers include:
- 250135 (Almus)
- 250399 (Almus)
- 250125 (Numark)
- 250109 (Aspar)
If you see these numbers or notice any visible damage to the silver foil on your blister strips, do not use the medication. Return the pack to your local pharmacy for a safe disposal and replacement.
The Importance of “Stability” in Medicine
You might wonder why a change in “appearance” or a “tiny hole” matters so much. As a health professional, I look at medicines as precise chemical formulas.
- Stability: Ensures that the active ingredient (like Melatonin) stays at the right strength to help you sleep.
- Packaging: Acts as a shield. Once that shield is broken by a perforation, the “shelf life” of the drug is no longer guaranteed.
If you or your child have taken these medications recently, don’t panic. No adverse reactions have been reported in connection with these specific recalls. However, always stay vigilant.
Health Disclaimer
This article is for informational purposes and does not replace professional medical advice. If you have concerns about a medication you are currently taking, please contact your GP or pharmacist. Report any suspected side effects via the MHRA Yellow Card Scheme. DrugsArea
Sources & References
- MHRA Class 2 Recall: KidNaps Melatonin (Feb 2026),
- MHRA Class 3 Recall: Aspar Ibuprofen (Feb 2026),
- Community Pharmacy England Safety Alerts,
- The Pharmacist: Sleep Medicine Recall News